$ADMA
ADMA BIOLOGICS, INC.

2021 Q3 Form 10-Q Financial Statement

#000114036121037463 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $20.68M $10.28M $7.788M
YoY Change 101.24% 42.28% 18.7%
Cost Of Revenue $20.30M $11.86M $13.50M
YoY Change 71.19% 49.76% 28.64%
Gross Profit $385.3K -$1.579M -$5.708M
YoY Change -124.4% 127.63% 45.23%
Gross Profit Margin 1.86% -15.37% -73.3%
Selling, General & Admin $13.87M $10.33M $9.580M
YoY Change 34.3% 35.03% 43.41%
% of Gross Profit 3600.2%
Research & Development $770.6K $1.708M $1.656M
YoY Change -54.9% 247.66% -17.18%
% of Gross Profit 199.97%
Depreciation & Amortization $1.200M $900.0K $700.0K
YoY Change 33.33% 9.76% 16.67%
% of Gross Profit 311.41%
Operating Expenses $14.82M $24.08M $24.91M
YoY Change -38.44% 47.96% 39.17%
Operating Profit -$14.44M -$13.80M -$17.12M
YoY Change 4.61% 52.49% 51.02%
Interest Expense -$3.294M $3.091M $3.067M
YoY Change -206.57% 16.68% 47.99%
% of Operating Profit
Other Income/Expense, Net $18.55K -$3.116M -$3.054M
YoY Change -100.6% 30.5% 63.05%
Pretax Income -$17.71M -$16.92M -$20.18M
YoY Change 4.69% 47.9% 52.76%
Income Tax
% Of Pretax Income
Net Earnings -$17.71M -$16.92M -$20.18M
YoY Change 4.7% 47.9% 52.73%
Net Earnings / Revenue -85.65% -164.62% -259.11%
Basic Earnings Per Share -$0.13
Diluted Earnings Per Share -$132.4K -$192.9K -$233.7K
COMMON SHARES
Basic Shares Outstanding 132.8M 86.35M shares
Diluted Shares Outstanding 133.8M

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.41M $59.70M $75.80M
YoY Change -42.36% 24.38% 2.99%
Cash & Equivalents $34.41M $59.68M $75.78M
Short-Term Investments
Other Short-Term Assets $5.859M $3.800M $4.700M
YoY Change 54.19% 123.53% 193.75%
Inventory $114.1M $69.75M $56.00M
Prepaid Expenses
Receivables $20.39M $6.335M $6.514M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $174.8M $139.5M $143.0M
YoY Change 25.25% 43.42% 37.62%
LONG-TERM ASSETS
Property, Plant & Equipment $48.39M $39.62M $37.37M
YoY Change 22.14% 29.06% 27.12%
Goodwill $3.500M $3.530M $3.530M
YoY Change -0.84%
Intangibles $2.623M $2.802M
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.334M $1.900M $4.800M
YoY Change 75.45% -32.14% 71.43%
Total Long-Term Assets $63.86M $50.43M $48.55M
YoY Change 26.63% 24.51% 23.23%
TOTAL ASSETS
Total Short-Term Assets $174.8M $139.5M $143.0M
Total Long-Term Assets $63.86M $50.43M $48.55M
Total Assets $238.6M $190.0M $191.5M
YoY Change 25.62% 37.86% 33.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.28M $7.980M $6.910M
YoY Change 116.58% -11.34% 1.61%
Accrued Expenses $13.03M $8.075M $5.617M
YoY Change 61.36% 61.5% 75.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $32.34M $16.47M $12.88M
YoY Change 96.3% 8.38% 27.53%
LONG-TERM LIABILITIES
Long-Term Debt $94.36M $97.00M $96.60M
YoY Change -2.72% 17.29% 17.23%
Other Long-Term Liabilities $9.160M $67.81K $80.73K
YoY Change 13408.72% -98.22% -97.93%
Total Long-Term Liabilities $103.5M $67.81K $80.73K
YoY Change 152570.78% -99.92% -99.91%
TOTAL LIABILITIES
Total Short-Term Liabilities $32.34M $16.47M $12.88M
Total Long-Term Liabilities $103.5M $67.81K $80.73K
Total Liabilities $135.9M $118.6M $114.7M
YoY Change 14.55% 16.62% 18.94%
SHAREHOLDERS EQUITY
Retained Earnings -$321.1M -$304.1M
YoY Change
Common Stock $8.962K $8.635K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $102.8M $71.38M $76.88M
YoY Change
Total Liabilities & Shareholders Equity $238.6M $190.0M $191.5M
YoY Change 25.62% 37.86% 33.66%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$17.71M -$16.92M -$20.18M
YoY Change 4.7% 47.9% 52.73%
Depreciation, Depletion And Amortization $1.200M $900.0K $700.0K
YoY Change 33.33% 9.76% 16.67%
Cash From Operating Activities -$13.41M -$23.85M -$21.28M
YoY Change -43.76% 0.93% 14.29%
INVESTING ACTIVITIES
Capital Expenditures -$2.789M -$2.890M -$4.170M
YoY Change -3.51% 46.7% 2878.57%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$2.789M -$2.890M -$4.170M
YoY Change -3.51% 46.7% 2878.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 8.203M 10.63M 0.000
YoY Change -22.83% -106400.0% -100.0%
NET CHANGE
Cash From Operating Activities -13.41M -23.85M -21.28M
Cash From Investing Activities -2.789M -2.890M -4.170M
Cash From Financing Activities 8.203M 10.63M 0.000
Net Change In Cash -7.998M -16.11M -25.45M
YoY Change -50.35% -37.09% -144.59%
FREE CASH FLOW
Cash From Operating Activities -$13.41M -$23.85M -$21.28M
Capital Expenditures -$2.789M -$2.890M -$4.170M
Free Cash Flow -$10.62M -$20.96M -$17.11M
YoY Change -49.31% -3.23% -7.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001368514
CY2021Q1 adma Vesting Of Restricted Stock Units Net Of Shares Withheld For Taxes And Retired Amount
VestingOfRestrictedStockUnitsNetOfSharesWithheldForTaxesAndRetiredAmount
-59311
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-18379941
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-18905303
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
111593532
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
8213602
CY2021Q3 adma Vesting Of Restricted Stock Units Net Of Shares Withheld For Taxes And Retired Amount
VestingOfRestrictedStockUnitsNetOfSharesWithheldForTaxesAndRetiredAmount
-2287
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
688274
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-17712954
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
102780167
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-19245230
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-20178091
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
76879455
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
774784
CY2020Q3 adma Vesting Of Restricted Stock Units Value
VestingOfRestrictedStockUnitsValue
0
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10639168
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-16917453
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
71375954
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
67300000
CY2020Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q3 adma Accounts Receivable Allowance For Contractual Credits And Doubtful Accounts
AccountsReceivableAllowanceForContractualCreditsAndDoubtfulAccounts
200000
CY2020Q4 adma Accounts Receivable Allowance For Contractual Credits And Doubtful Accounts
AccountsReceivableAllowanceForContractualCreditsAndDoubtfulAccounts
100000
CY2021Q3 us-gaap Goodwill
Goodwill
3500000
CY2020Q4 us-gaap Goodwill
Goodwill
3500000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16828915
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9407511
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P10Y
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
37926168
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
32044393
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
57264112
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
30293288
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
18932593
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
19197918
CY2021Q3 us-gaap Inventory Net
InventoryNet
114122873
CY2020Q4 us-gaap Inventory Net
InventoryNet
81535599
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6084024
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4176417
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1907607
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6084024
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3639903
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2444121
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
178838
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths
715352
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo
715352
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Rolling Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree
298065
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60589916
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
50457032
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12196193
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8863942
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48393723
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
41593090
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1200000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3400000
CY2020Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
900000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2200000
CY2021Q3 adma Accrued Rebates Current
AccruedRebatesCurrent
4507995
CY2020Q4 adma Accrued Rebates Current
AccruedRebatesCurrent
2604245
CY2021Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1981281
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
828120
CY2021Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1763546
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
734972
CY2021Q3 us-gaap Liability Premium Deficiency Testing On Long Duration Contract Amount
LiabilityPremiumDeficiencyTestingOnLongDurationContractAmount
1259871
CY2020Q4 us-gaap Liability Premium Deficiency Testing On Long Duration Contract Amount
LiabilityPremiumDeficiencyTestingOnLongDurationContractAmount
779660
CY2021Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
2391630
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3210884
CY2021Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
624522
CY2020Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
0
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1881484
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
207262
CY2021Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
14410329
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
8365143
CY2021Q3 adma Senior Notes Payable Before Debt Discount
SeniorNotesPayableBeforeDebtDiscount
100000000
CY2020Q4 adma Senior Notes Payable Before Debt Discount
SeniorNotesPayableBeforeDebtDiscount
100000000
CY2021Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
5636992
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
7031134
CY2021Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
94363008
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
92968866
CY2021Q3 adma Senior Notes Payable Before Debt Discount
SeniorNotesPayableBeforeDebtDiscount
100000000.0
adma Repayments Of Debt Interest
RepaymentsOfDebtInterest
8300000
adma Repayments Of Debt Interest
RepaymentsOfDebtInterest
6800000
CY2021Q3 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
10000000
CY2020Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
10000000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
138313817
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
104902888
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16828915
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
144641489
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.82
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.82
adma Percentage Of Inventory Purchases
PercentageOfInventoryPurchases
0.69
adma Plasma Purchased
PlasmaPurchased
13800000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
688274
CY2020Q3 us-gaap Share Based Compensation
ShareBasedCompensation
774784
us-gaap Share Based Compensation
ShareBasedCompensation
2274860
us-gaap Share Based Compensation
ShareBasedCompensation
2166940
adma Plasma Supply Agreement Term
PlasmaSupplyAgreementTerm
P10Y
adma Plasma Purchased
PlasmaPurchased
31200000
adma Percentage Of Inventory Purchases
PercentageOfInventoryPurchases
0.66
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
12780339
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5363350
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
501239
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6915750
adma Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.13
CY2021Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2020Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
200000
us-gaap Operating Lease Expense
OperatingLeaseExpense
1000000.0
us-gaap Operating Lease Expense
OperatingLeaseExpense
400000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
100000
us-gaap Operating Lease Payments
OperatingLeasePayments
700000
us-gaap Operating Lease Payments
OperatingLeasePayments
300000
CY2021Q3 adma Lessee Operating Lease Liabilities Related To Property Lease
LesseeOperatingLeaseLiabilitiesRelatedToPropertyLease
2800000
CY2021Q3 adma Lessee Operating Lease Right Of Use Asset Related To Property Lease
LesseeOperatingLeaseRightOfUseAssetRelatedToPropertyLease
2800000
adma Number Of New Property Leases
NumberOfNewPropertyLeases
3
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
7400000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
4700000
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
312470
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1512443
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1526406
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1399474
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1405411
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1137321
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
5486814
CY2021Q2 us-gaap Security Deposit
SecurityDeposit
300000
CY2021Q2 us-gaap Payments For Rent
PaymentsForRent
0
CY2021Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P90M

Files In Submission

Name View Source Status
0001140361-21-037463-index-headers.html Edgar Link pending
0001140361-21-037463-index.html Edgar Link pending
0001140361-21-037463.txt Edgar Link pending
0001140361-21-037463-xbrl.zip Edgar Link pending
adma-20210930.xsd Edgar Link pending
adma-20210930_cal.xml Edgar Link unprocessable
adma-20210930_def.xml Edgar Link unprocessable
adma-20210930_lab.xml Edgar Link unprocessable
adma-20210930_pre.xml Edgar Link unprocessable
brhc10030513_10q.htm Edgar Link pending
brhc10030513_10q_htm.xml Edgar Link completed
brhc10030513_ex31-1.htm Edgar Link pending
brhc10030513_ex31-2.htm Edgar Link pending
brhc10030513_ex32-1.htm Edgar Link pending
brhc10030513_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending